Yi Hu
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 169
- Cancer Immunotherapy and Biomarkers 69
- Lung Cancer Research Studies 43
- Colorectal Cancer Treatments and Studies 23
-
- Lung Cancer Treatments and Mutations 77
- Lung Cancer Diagnosis and Treatment 25
- Gastric Cancer Management and Outcomes 18
- Ferroptosis and cancer prognosis 17
- Co-authors
- Yangzhe Wu (9 shared papers)Haitao Tao (42 shared papers)Jinliang Wang (32 shared papers)Shunchang Jiao (21 shared papers)Yixue Xue (12 shared papers)Sujie Zhang (17 shared papers)Yijia Li (4 shared papers)Zhibo Zhang (14 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Frontiers in Oncology (16 papers)Frontiers in Immunology (7 papers)Cancer Medicine (7 papers)Cancer Immunology Immunotherapy (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yi Hu
288 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 2.2k
- Cancer Research 1.1k
- Immunology 884
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 1.8k
Countries citing papers authored by Yi Hu
This map shows the geographic impact of Yi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hu more than expected).
Fields of papers citing papers by Yi Hu
This network shows the impact of papers produced by Yi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hu. The network helps show where Yi Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 314 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer Hit paper breakdown → | 2021 | 253 |
| 2 | Programmed Cell Death Tunes Tumor Immunity Hit paper breakdown → | 2022 | 231 |
| 3 | γδ T cells: origin and fate, subsets, diseases and immunotherapy Hit paper breakdown → | 2023 | 152 |
| 4 | 2015 | 115 | |
| 5 | 2019 | 110 | |
| 6 | 2015 | 104 | |
| 7 | 2010 | 93 | |
| 8 | 2019 | 91 | |
| 9 | 2018 | 90 | |
| 10 | 2021 | 83 | |
| 11 | 2019 | 83 | |
| 12 | 2020 | 66 | |
| 13 | 2014 | 62 | |
| 14 | 2011 | 59 | |
| 15 | 2014 | 57 | |
| 16 | 2014 | 56 | |
| 17 | 2020 | 52 | |
| 18 | 2019 | 50 | |
| 19 | 2014 | 48 | |
| 20 | 2013 | 47 |
About Yi Hu
Yi Hu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 314 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (77 papers), Cancer Immunotherapy and Biomarkers (69 papers), Lung Cancer Research Studies (43 papers), Lung Cancer Diagnosis and Treatment (25 papers), Colorectal Cancer Treatments and Studies (23 papers), Cancer-related molecular mechanisms research (20 papers), Gastric Cancer Management and Outcomes (18 papers) and Ferroptosis and cancer prognosis (17 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (1.1k citations), Immunology (884 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Molecular Biology (1.8k citations). Yi Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yangzhe Wu, Haitao Tao, Jinliang Wang, Shunchang Jiao, Yixue Xue, Sujie Zhang, Yijia Li, Zhibo Zhang, Junxun Ma and Dan Chen. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Frontiers in Immunology, Cancer Medicine and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.